BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
See today's BioWorld
Home
» Positive news: Astrazeneca vaccine still effective in B.1.1.7 SARS-CoV-2 variant
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Positive news: Astrazeneca vaccine still effective in B.1.1.7 SARS-CoV-2 variant
Feb. 5, 2021
By
Nuala Moran
No Comments
LONDON – A follow-up study of participants in the phase II/III U.K. trial of
Astrazeneca plc
’s COVID-19
vaccine
has shown it remains effective against the new B.1.1.7 variant of SARS-CoV-2.
BioWorld
Clinical
Coronavirus
Vaccine
Europe